Cross Country Healthcare (NASDAQ:CCRN – Get Free Report) updated its second quarter earnings guidance on Wednesday. The company provided earnings per share guidance of $0.10-0.20 for the period, compared to the consensus earnings per share estimate of $0.19. The company issued revenue guidance of $330-340 million, compared to the consensus revenue estimate of $362.62 million. Cross Country Healthcare also updated its Q2 2024 guidance to 0.100-0.200 EPS.
Analyst Ratings Changes
A number of brokerages have recently commented on CCRN. Benchmark dropped their price target on Cross Country Healthcare from $21.00 to $19.00 and set a buy rating on the stock in a research report on Thursday. Truist Financial dropped their price objective on shares of Cross Country Healthcare from $22.00 to $16.00 and set a hold rating on the stock in a report on Thursday, February 22nd. Barrington Research reduced their target price on shares of Cross Country Healthcare from $26.00 to $24.00 and set an outperform rating for the company in a research note on Tuesday, February 27th. Finally, TheStreet lowered shares of Cross Country Healthcare from a b- rating to a c+ rating in a research report on Friday, March 1st. Six equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of Hold and a consensus target price of $21.33.
View Our Latest Report on CCRN
Cross Country Healthcare Trading Down 0.4 %
Cross Country Healthcare (NASDAQ:CCRN – Get Free Report) last announced its quarterly earnings results on Wednesday, May 1st. The business services provider reported $0.19 EPS for the quarter, beating the consensus estimate of $0.17 by $0.02. Cross Country Healthcare had a net margin of 2.58% and a return on equity of 11.69%. The firm had revenue of $379.17 million during the quarter, compared to the consensus estimate of $374.38 million. During the same period last year, the firm earned $0.84 EPS. The business’s quarterly revenue was down 39.1% compared to the same quarter last year. On average, equities analysts anticipate that Cross Country Healthcare will post 0.9 EPS for the current fiscal year.
Insider Activity
In related news, insider Karen Mote sold 6,216 shares of the firm’s stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $16.95, for a total value of $105,361.20. Following the sale, the insider now directly owns 35,101 shares of the company’s stock, valued at $594,961.95. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 4.90% of the company’s stock.
Cross Country Healthcare Company Profile
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Featured Articles
- Five stocks we like better than Cross Country Healthcare
- Stock Market Sectors: What Are They and How Many Are There?
- MarketBeat Week in Review – 4/29 – 5/3
- What is a Death Cross in Stocks?
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- How to Most Effectively Use the MarketBeat Earnings Screener
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.